Literature DB >> 24868321

Gender and racial differences in nonalcoholic fatty liver disease.

Jen-Jung Pan1, Michael B Fallon1.   

Abstract

Due to the worldwide epidemic of obesity, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of elevated liver enzymes. NAFLD represents a spectrum of liver injury ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) which may progress to advanced fibrosis and cirrhosis. Individuals with NAFLD, especially those with metabolic syndrome, have higher overall mortality, cardiovascular mortality, and liver-related mortality compared with the general population. According to the population-based studies, NAFLD and NASH are more prevalent in males and in Hispanics. Both the gender and racial ethnic differences in NAFLD and NASH are likely attributed to interaction between environmental, behavioral, and genetic factors. Using genome-wide association studies, several genetic variants have been identified to be associated with NAFLD/NASH. However, these variants account for only a small amount of variation in hepatic steatosis among ethnic groups and may serve as modifiers of the natural history of NAFLD. Alternatively, these variants may not be the causative variants but simply markers representing a larger body of genetic variations. In this article, we provide a concise review of the gender and racial differences in the prevalence of NAFLD and NASH in adults. We also discuss the possible mechanisms for these disparities.

Entities:  

Keywords:  Gender; Genetic polymorphism; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Prevalence; Race

Year:  2014        PMID: 24868321      PMCID: PMC4033285          DOI: 10.4254/wjh.v6.i5.274

Source DB:  PubMed          Journal:  World J Hepatol


  78 in total

1.  Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Authors:  Yoshinori Miyazaki; Leonard Glass; Curtis Triplitt; Estela Wajcberg; Lawrence J Mandarino; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-12       Impact factor: 4.310

2.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.

Authors:  Lynne E Wagenknecht; Nicholette D Palmer; Donald W Bowden; Jerome I Rotter; Jill M Norris; Julie Ziegler; Yii-Der I Chen; Steven Haffner; Ann Scherzinger; Carl D Langefeld
Journal:  Liver Int       Date:  2011-01-13       Impact factor: 5.828

4.  Prevalence of fatty liver in a general population of Okinawa, Japan.

Authors:  H Nomura; S Kashiwagi; J Hayashi; W Kajiyama; S Tani; M Goto
Journal:  Jpn J Med       Date:  1988-05

5.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

Review 6.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

7.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

8.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

9.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

10.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002

View more
  95 in total

1.  Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models.

Authors:  Austin Morrell; Brian P Tripet; Brian J Eilers; Megan Tegman; Damon Thompson; Valérie Copié; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2019-12-16       Impact factor: 6.048

Review 2.  Gender-based disparities in access to and outcomes of liver transplantation.

Authors:  Omobonike O Oloruntoba; Cynthia A Moylan
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

Review 4.  Sex differences in metabolism and cardiometabolic disorders.

Authors:  Karthickeyan Chella Krishnan; Margarete Mehrabian; Aldons J Lusis
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

5.  Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial.

Authors:  Maret G Traber; Eunice Mah; Scott W Leonard; Gerd Bobe; Richard S Bruno
Journal:  Am J Clin Nutr       Date:  2017-01-11       Impact factor: 7.045

6.  Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Shelly C Lu; Loïc Le Marchand; Mazen Noureddin
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

7.  Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.

Authors:  Wenjin Ding; Jiangao Fan; Jianjun Qin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 8.  Genetic Basis for Sex Differences in Obesity and Lipid Metabolism.

Authors:  Jenny C Link; Karen Reue
Journal:  Annu Rev Nutr       Date:  2017-06-19       Impact factor: 11.848

Review 9.  Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.

Authors:  Monica M Betancourt-Garcia; Armando Arguelles; Jorge Montes; Ambrosio Hernandez; Manish Singh; R Armour Forse
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

Review 10.  Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.

Authors:  Lindsey S Treviño; Tiffany A Katz
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.